ctrl K

LENZ Therapeutics Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

29.66

0.78 (2.70%)

At close: May 02, 2025, 3:59 PM

31.50

6.20%

After-hours: May 02, 2025, 05:04 PM EDT

LENZ Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	15M	n/a	n/a	n/a
Cost of Revenue	58K	2.41M	8.35M	734K	121K	n/a
Gross Profit	-58K	-2.41M	6.65M	-734K	-121K	n/a
Operating Income	-58.61M	-73.11M	-105.64M	-60.44M	-13.5M	-29K
Interest Income	8.55M	2.19M	n/a	n/a	n/a	n/a
Pretax Income	-49.77M	-124.65M	-101.05M	-70.76M	-68.37M	-109K
Net Income	-49.77M	-124.65M	-101.05M	-70.76M	-68.37M	-109K
Selling & General & Admin	28.75M	40.97M	32.85M	21.78M	4.26M	29K
Research & Development	29.8M	29.73M	64.44M	37.93M	9.12M	n/a
Other Expenses	n/a	n/a	19K	-869K	n/a	n/a
Operating Expenses	58.55M	70.7M	97.29M	59.71M	13.38M	29K
Interest Expense	n/a	n/a	n/a	n/a	40K	80K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-58.61M	73.11M	105.64M	60.44M	13.5M	29K
Income Tax Expense	1K	-179K	347K	497.44K	n/a	-171.86K
Shares Outstanding (Basic)	21.28M	8.15M	7.84M	8.29M	8.3M	8.3M
Shares Outstanding (Diluted)	21.28M	8.15M	7.84M	8.29M	8.3M	8.3M
EPS (Basic)	-2.34	-15.3	-12.89	-8.54	-8.24	-0.01
EPS (Diluted)	-2.34	-15.3	-12.89	-8.54	-8.24	-0.01
EBITDA	-49.71M	-122.24M	-97.29M	-70.03M	-68.21M	-29K
EBIT	-49.77M	-124.65M	-10.48M	-70.76M	-68.33M	-29K
Depreciation & Amortization	58K	15K	8.35M	734K	121K	171.86K